Constipation is the GLP-1 side effect nobody posts about. Nausea gets all the attention, but backed-up, uncomfortable, why-haven't-I-gone-in-days constipation is a commonly reported digestive complaint. It often shows up in the first few weeks or after a dose increase. Here is the good news: it usually responds to a few simple, consistent habits. And here is the trap most people fall into, the one that quietly makes it worse: piling on fiber without enough water. Some people may drink less without noticing, so let's fix the root cause instead of just focusing on the symptom.
Why Do GLP-1s Cause Constipation?
GLP-1 medications can contribute to constipation by slowing gastrointestinal transit. When stool moves through the colon more slowly, the colon absorbs more water from it, leaving it hard and dry. Reduced food, fiber, and fluid intake can compound the effect, especially in the first few weeks of therapy.
It helps to see this as an extension of how the drug is designed to work. By slowing gastric emptying, a GLP-1 can keep you feeling full longer, and slower overall transit may leave stool drier and denser. On top of the mechanics, you may be eating and drinking less, so there is less bulk and fluid moving things along. It is common: constipation was reported in 24% of patients taking semaglutide 2.4 mg in STEP 1 versus 11% with placebo, while reported rates vary by medication and dose.[1] For the full picture of how these medications reshape digestion, see what GLP-1s do to your digestion.
What Actually Helps Constipation on a GLP-1?
Relief comes from deliberate hydration and gradual fiber working together. Adding fiber quickly without enough fluid may worsen bloating or constipation, so consistent hydration is an important first step, paired with gentle movement and regular meals to support normal motility.
Start with the trap, because it is the single most important thing here: some people on GLP-1s may drink less without noticing. If you then load up on dry fiber, like a heaping scoop of psyllium, without increasing your fluids, symptoms may get worse. Hydrate intentionally and consistently, not just when you feel thirsty.[2] Electrolyte problems can affect normal muscle and nerve function, but do not add high-dose potassium or sodium just to treat constipation. Ask your provider first, especially if you have kidney disease or take blood-pressure or heart medications; see potassium and electrolytes on GLP-1s for the full picture. Then build fiber gradually, favoring gentle soluble fiber over a large dose on a slowed gut all at once, which may trigger gas and bloating. Add gentle daily movement and reasonably regular meal timing, both of which can support normal motility. Because reduced overall intake is part of what drives this, it is worth being intentional about food quality too.[3] For practical meals, see what to eat on a GLP-1, and for why fluid is so central, hydration on a GLP-1. For a deeper look at the gut-barrier and microbiome side of motility, this guide on colostrum and digestive regularity is a useful resource.
Does Magnesium Help With Regularity on a GLP-1?
Magnesium supports normal muscle contraction and nerve signaling, both of which matter for healthy bowel motility. It may be one option to discuss with a healthcare professional when food intake is low, but it is not a universal constipation treatment.
Think of magnesium as supporting normal function rather than as a forceful laxative. Form matters for tolerance: magnesium citrate can draw water into the bowel and may loosen stool, while ionic forms are often chosen by people who prefer a gentler routine. Individual responses vary, and anyone with kidney disease or medication concerns should ask a clinician before supplementing. Timing matters too, so for how to fit magnesium and other supplements into a GLP-1 routine, see supplement timing on a GLP-1. An HTMA test may provide complementary, non-diagnostic mineral-pattern context, but it cannot confirm magnesium deficiency or replace clinical testing. A product such as Upgraded Magnesium may be an option to discuss for normal muscle function and routine support. For the full rundown on this mineral, see magnesium on GLP-1s.
When Is Constipation a Red Flag?
Routine constipation is common and manageable, but some symptoms need prompt medical attention. A few days without a bowel movement can happen, but severe abdominal pain, persistent vomiting, marked swelling, or an inability to pass gas are reasons to seek urgent medical care rather than waiting it out.
The reason to take those signs seriously, without panicking, is that severe, unresolved constipation can occasionally occur alongside something more serious like a bowel obstruction or ileus, a stalling of the intestine's normal movement. Those are uncommon but real, and they are exactly why the red flags above mean "get evaluated now." The FDA label reviewed for this article lists ileus, intestinal obstruction, and severe constipation including fecal impaction in postmarketing experience; these reports do not establish how common the events are or prove causation.[2] Laxative choices are clinical decisions, so let your provider guide them. Osmotic agents are sometimes recommended for short-term use, while stimulant products should not become a routine self-treatment without medical guidance. If constipation persists despite reasonable hydration and gradual fiber habits, check in with your provider, who may want to review your dose or titration pace. Never adjust it on your own. If your symptoms feel more like fullness and vomiting from the top down rather than a lower-bowel backup, it is worth understanding the difference; see GLP-1s and gastroparesis.
Frequently Asked Questions
Is constipation a common side effect of Wegovy or Zepbound?
Yes. It is a commonly reported digestive side effect and was reported in 24% of patients taking semaglutide 2.4 mg in STEP 1. Rates vary by medication and dose, and symptoms are often worst during the first few weeks or after a dose increase.
Why is my constipation worse since I started eating more protein?
A high-protein eating pattern can displace fiber-rich foods or fluids if it is not balanced, which may slow things further. Pair protein with fiber-rich foods and adequate fluids as tolerated to help maintain normal motility.
Can I take a laxative to help things move?
Sometimes, but let your provider guide it. Osmotic products are sometimes used for short-term relief, while stimulant laxatives should not become a routine self-treatment without medical guidance. Always clear laxative use with your prescribing doctor first.
How does an HTMA test help with my digestion?
HTMA may provide complementary, non-diagnostic mineral-pattern context, but it cannot diagnose the cause of constipation or confirm that you are low in magnesium. It does not replace clinical evaluation or clinician-ordered testing, so pair any result with your provider's guidance.
Small Habits, Real Relief
Constipation on a GLP-1 is common and often manageable once you address the basics instead of chasing the symptom. Hydrate on purpose, build fiber gradually, keep moving, discuss magnesium or laxative options with your provider, and know the red flags that mean it is time to call for care. For the bigger picture, start with the hidden nutrient gaps behind GLP-1 weight loss.
Rapid change on the outside. Steady support on the inside. Your minerals and nutrients, in your control.
References
- Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989-1002. doi:10.1056/NEJMoa2032183 · PMID 33567185 · PMC8089593. Also: WEGOVY (semaglutide) injection, Prescribing Information, section 6.1, revised June 2026, via DailyMed; and ZEPBOUND (tirzepatide) injection, Prescribing Information, revised February 2026, accessdata.fda.gov. (Constipation was reported in 24% of patients on semaglutide 2.4 mg versus 11% on placebo; reported rates vary by medication and dose. Slowed gastric emptying and reduced intake can contribute to harder stool.)
- Mozaffarian D, Agarwal M, Aggarwal M, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Obesity (Silver Spring). 2025;33(8):1475-1503. doi:10.1002/oby.24336 · PMID 40445127 · PMC12304835. Also: Almandoz JP, Wadden TA, Tewksbury C, et al. Nutritional considerations with antiobesity medications. Obesity (Silver Spring). 2024;32(9):1613-1631. doi:10.1002/oby.24067 · PMID 38853526. And: WEGOVY Prescribing Information, section 6.2 (Postmarketing Experience), which lists "ileus, intestinal obstruction, severe constipation including fecal impaction." (Hydration, gradual soluble fiber, movement, and provider-guided laxative decisions; postmarketing obstruction and ileus reports support urgent evaluation of severe pain, persistent vomiting, marked swelling, or inability to pass gas, without establishing frequency or causation.)
- Urbina J, et al. Micronutrient and Nutritional Deficiencies Associated With GLP-1 Receptor Agonist Therapy: A Narrative Review. Clin Obes. 2026;16(1):e70070. doi:10.1111/cob.70070 · PMID 41549912. (Reduced overall intake as a driver of nutrient gaps and reduced dietary bulk during therapy.)
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.